Literature DB >> 22443271

Contemporary trends of in-hospital complications and mortality for radical cystectomy.

Simon P Kim1, Stephen A Boorjian, Nilay D Shah, R Jeffrey Karnes, Christopher J Weight, James P Moriarty, Matthew K Tollefson, Nathan D Shippee, Igor Frank.   

Abstract

UNLABELLED: What's known on the subject? and What does the study add? Radical cystectomy (RC) carries significant risks of morbidity and mortality. Little is known whether in-hospital outcomes are improving for RC. Using a contemporary population-based cohort, the present study suggests minimal improvement in postoperative complications and mortality overall or by hospital-volume category from 2001 to 2008. About 29% and 2% of patients undergoing RC will experience a postoperative complication or die during hospitalisation, respectively.
OBJECTIVE: To characterise the contemporary trends of in-hospital complications and mortality for radical cystectomy (RC) from a contemporary population-based cohort, as patients undergoing RC for bladder cancer are at significant risk for complications and mortality and the degree to which in-hospital outcomes have changed over time is unknown. PATIENTS AND METHODS: We identified 50 625 individuals who underwent RC for bladder cancer between 2001 and 2008 from the Nationwide Inpatient Sample. Multivariable regression models were used to identify hospital and patient covariates associated with in-hospital complications and mortality and to estimate predicted probabilities of each outcome. Temporal trends of in-hospital mortality and complications were assessed by Wilcoxon rank-sum test.
RESULTS: The proportion of patients with in-hospital complications remained stable at 28.3% in 2001-2002 compared with 28.0% in 2007-2008 (P = 0.81 for trend). In-hospital mortality was also unchanged from 2.4% in 2001-2002 compared with 2.3% in 2007-2008 (P = 0.87 for trend). While high-volume hospitals were associated with lower odds of in-hospital complications (odds ratio [OR] 0.77, P = 0.01) and mortality (OR 0.60, P = 0.02) compared with low-volume hospitals, the predicted probabilities of in-hospital complications or mortality were unchanged within each volume category between 2001 and 2008.
CONCLUSIONS: In-hospital complications and mortality for RC remain unchanged from 2001 to 2008. While high-volume hospitals continue to have better outcomes, there is little evidence that postoperative mortality and morbidity are improving among low-, medium- and high-volume hospitals. Increased attention is needed to identify the modifiable aspects of postoperative care to improve in-hospital outcomes and safety for patients undergoing RC.
© 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2012        PMID: 22443271     DOI: 10.1111/j.1464-410X.2012.10990.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  16 in total

1.  Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort.

Authors:  Florian Roghmann; Andreas Becker; Quoc-Dien Trinh; Orchidee Djahangirian; Orchidee Djahagirian; Zhe Tian; Malek Meskawi; Shahrokh F Shariat; Markus Graefen; Pierre Karakiewicz; Joachim Noldus; Maxine Sun
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

2.  Involving Patients in the Development and Evaluation of an Educational and Training Experiential Intervention (ETEI) to Improve Muscle Invasive Bladder Cancer Treatment Decision-making and Post-operative Self-care: a Mixed Methods Approach.

Authors:  Nihal Mohamed; Tung Ming Leung; Qainat N Shah; Sailaja Pisipati; Donna L Berry; Emma K T Benn; Cheryl T Lee; Simon Hall; Reza Mehrazin; John Sfakianos
Journal:  J Cancer Educ       Date:  2020-08       Impact factor: 2.037

3.  Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.

Authors:  Coleman McFerrin; Syed Johar Raza; Allison May; Facundo Davaro; Sameer Siddiqui; Zachary Hamilton
Journal:  Int Urol Nephrol       Date:  2019-07-25       Impact factor: 2.370

4.  [Morbidity, mortality, and overall survival after radical cystectomy: comparison of single-center results with the literature and a nomogram].

Authors:  C Brunken; S Tauber; P Wohlmuth
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

5.  Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database.

Authors:  Giorgio Gandaglia; Briony Varda; Akshay Sood; Daniel Pucheril; Ramdev Konijeti; Jesse D Sammon; Shyam Sukumar; Mani Menon; Maxine Sun; Steven L Chang; Francesco Montorsi; Adam S Kibel; Quoc-Dien Trinh
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

Review 6.  Bladder Cancer Survivorship.

Authors:  Sumeet K Bhanvadia
Journal:  Curr Urol Rep       Date:  2018-11-09       Impact factor: 3.092

7.  Perioperative outcomes after radical cystectomy at NCI-designated centres: Are they any better?

Authors:  Florian Roghmann; Praful Ravi; Julian Hanske; Christian P Meyer; Mark A Preston; Joachim Noldus; Quoc-Dien Trinh
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

Review 8.  [Radical cystectomy and urinary diversion-what is important ?]

Authors:  J Noldus; G Niegisch; A Pycha; A Karl
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

9.  Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients.

Authors:  Mieke van Hemelrijck; Andreas Thorstenson; Philip Smith; Jan Adolfsson; Olof Akre
Journal:  BJU Int       Date:  2013-07-26       Impact factor: 5.588

10.  Risk factors of postoperative complications after radical cystectomy with continent or conduit urinary diversion in Armenia.

Authors:  Arman Tsaturyan; Varduhi Petrosyan; Byron Crape; Yeva Sahakyan; Lusine Abrahamyan
Journal:  Springerplus       Date:  2016-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.